Publications - IR Sant Pau

Search

01/06/2025 Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study

Biagetti, B, Asanza, EC, Pérez-López, C, Araujo-Castro, M, Camara, R, Guerrero-Pérez, F, Vicente, A, Lamas, C, Serra, G, Echarri, AI, Ollero, MD, Molero, IG, Villar-Taibo, R, Rodríguez, MDM, Garcia-Feijoo, P, Berrocal, VR, Ramirez, MNS, Hurtado, AG, Capristan-Díaz, V, Simó-Servat, A, Gallach, M, Perez, ES, Rosa, VG, Civantos, S, Asensio-Wandosell, D, Martinez-Saez, E, Torre, EM, Aulinas, A, Iglesias, P, Diez, JJ, Bernábeu, I, Alvarez-Escolá, C, Puig-Domingo, M. Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(6)DOI:10.1210/clinem/dgae649. PMID:39298667. IF:5.100(Q1/2D).

01/02/2025 Increased copeptin may reflect vasopressin-related metabolic changes after bariatric surgery

Galbiati, F, Becetti, I, Lauze, M, Aulinas, A, Singhal, V, Bredella, MA, Lawson, EA, Misra, M. Increased copeptin may reflect vasopressin-related metabolic changes after bariatric surgery. Obesity. 2025; 33(2)DOI:10.1002/oby.24200. PMID:39725569. IF:4.700(Q1/2D).

01/02/2025 Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study

Guerrero-Pérez, F, Biagetti, B, Paja-Fano, M, Menéndez-Torre, EL, Rivero, G, Dios, E, Hanzu, FA, Rojas-Marcos, PM, Irigaray, A, Rodríguez, MDM, García-Centeno, R, Fernández, LG, Enseñat, J, Mora, M, Villar-Taibo, R, García, IMO, Araujo-Castro, M, Gándara, C, García, MDO, Tenorio-Jiménez, C, Novo-Rodriguez, C, Civantos, S, Simó-Servat, A, Aulinas, A, Asla, Q, Cordido, F, Novoa-Testa, I, Xifra, G, Ayala-Conte, M, Zamarron, A, Berrocal, MIG, Iglesias, P. Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study. Pituitary. 2025; 28(1)DOI:10.1007/s11102-024-01484-y. PMID:39733084. IF:3.400(Q2/4D).

01/09/2024 Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs (vol 31, e240043, 2024)

Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Pascual-Corrales, E, Berrocal, VR, Guerrero-Perez, F, Vicente, A, Hualpa, JCP, Garcia-Centeno, R, Gonzalez-Fernandez, L, Garcia, MDO, Echarri, AI, Rodriguez, MDM, Novo-Rodriguez, C, Calatayud, M, Villar-Taibo, R, Bernabeu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jimenez, C, Galiana, PA, Venegas, E, Gonzalez-Molero, I, Iglesias, P, Blanco-Carrera, C, De Lara, FVO, Novoa, PD, Mezquita, EL, Hanzu, FA, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Asla, Q, Gimeno, PG, Recio-Cordova, JM, Aviles-Perez, MD, Asensio-Wandosell, D, Sampedro-Nunez, M, Camara, R, Fano, MP, Ruz-Caracuel, I, Fajardo, C, Marazuela, M, Puig-Domingo, M. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs (vol 31, e240043, 2024). ENDOCRINE-RELATED CANCER. 2024; 31(9)DOI:10.1530/ERC-24-0043e. PMID:. IF:4.600(Q1/3D).

13/08/2024 Personalized Medicine in Acromegaly: The ACROFAST Study

Marques-Pamies, M, Gil, J, Sampedro-Nuñez, M, Valassi, E, Biagetti, B, Giménez-Palop, O, Hernández, M, Martínez, S, Carrato, C, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón-Muela, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, Rosado, JA, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Librizzi, S, Calatayud, M, de Miguel, P, Alvarez-Escola, C, Picó, A, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Puig-Domingo, M. Personalized Medicine in Acromegaly: The ACROFAST Study. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2024; 110(1)DOI:10.1210/clinem/dgae444. PMID:38943661. IF:5.100(Q1/2D).

01/08/2024 Association between inadequate weight gain according to the institute of medicine 2009 guidelines and pregnancy outcomes in women with thyroid disorders

Liu, JM, Xie, XL, García-Patterson, A, Asla, Q, Sardà, H, Chico, A, Adelantado, JM, Urgell, E, Corcoy, R. Association between inadequate weight gain according to the institute of medicine 2009 guidelines and pregnancy outcomes in women with thyroid disorders. ARCHIVES OF GYNECOLOGY AND OBSTETRICS. 2024; 310(2)DOI:10.1007/s00404-023-07279-z. PMID:37981602. IF:2.500(Q2/3D).

17/07/2024 Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing's syndrome: a pilot study

Seco-Cervera, M, Ibáñez-Cabellos, JS, Pallardo, FV, García-Giménez, JL, Aulinas, A, Martel-Duguech, L, Webb, SM, Valassi, E. Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing's syndrome: a pilot study. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1410080. PMID:39086897. IF:4.600(Q1/3D).

01/07/2024 Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Pascual-Corrales, E, Berrocal, VR, Guerrero-Pérez, F, Vicente, A, Hualpa, JCP, García-Centeno, R, González-Fernández, L, García, MDO, Echarri, AI, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar-Taibo, R, Bernabéu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jiménez, C, Galiana, PA, Venegas, E, González-Molero, I, Iglesias, P, Blanco-Carrera, C, De Lara, FVO, Novoa, PD, Mezquita, EL, Hanzu, FA, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Asla, Q, Gimeno, PG, Recio-Córdova, JM, Avilés-Pérez, MD, Asensio-Wandosell, D, Sampedro-Núñez, M, Cámara, R, Fano, MP, Ruz-Caracuel, I, Fajardo, C, Marazuela, M, Puig-Domingo, M. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs. ENDOCRINE-RELATED CANCER. 2024; 31(7)DOI:10.1530/ERC-24-0043. PMID:38713182. IF:4.600(Q1/3D).

28/06/2024 Medical Comorbidities, Nutritional Markers, and Cardiovascular Risk Markers in Youth With ARFID

Burton-Murray, H, Sella, AC, Gydus, JE, Atkins, M, Palmer, LP, Kuhnle, MC, Becker, KR, Breithaupt, LE, Brigham, KS, Aulinas, A, Staller, K, Eddy, KT, Misra, M, Micali, N, Thomas, JJ, Lawson, EA. Medical Comorbidities, Nutritional Markers, and Cardiovascular Risk Markers in Youth With ARFID. INTERNATIONAL JOURNAL OF EATING DISORDERS. 2024; 57(11)DOI:10.1002/eat.24243. PMID:38940228. IF:4.300(Q1/1D).

28/06/2024 Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

Pascual-Corrales, E, Biagetti, B, Marazuela, M, Asensio-Wandosel, D, Berrocal, VR, Echarri, AI, Novo-Rodriguez, C, Calatayud, M, Bernabeu, I, Alvarez-Escola, C, Tenorio-Jimenez, C, Molero, IG, Iglesias, P, Blanco, C, de Miguel, P, Mezquita, EL, Lamas, C, Aulinas, A, Gracia, P, Recio-Cordova, JM, Sampedro-Nunez, M, Paja, M, Rodríguez, MDM, Fajardo-Montañana, C, Cordido, F, Torre, EM, Percovich, JC, García-Centeno, R, Cámara, R, Hanzu, FA, Delgado, AV, Fernández, LG, Guerrero-Pérez, F, Garcia-Agullo, MDO, Novoa-Testa, I, Villar-Taibo, R, Valderrama, PB, Galiana, PA, Moreno, EV, De Lara, FVO, Enseñat, J, Aznar, S, Asla, Q, Aviles-Pérez, MD, Puig-Domingo, M, Araujo-Castro, M. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly. Pituitary. 2024; 27(5)DOI:10.1007/s11102-024-01415-x. PMID:38940859. IF:3.400(Q2/4D).

17/06/2024 Natural history and surgical outcomes of Rathke's cleft cysts: a Spanish multicenter study

Menéndez-Torre, EL, Gutiérrez-Hurtado, A, Ollero, MD, Irigaray, A, Martín, P, Parra, P, González-Molero, I, Araujo-Castro, M, Idrobo, C, Moure, MD, Molina, AR, Biagetti, B, Iglesias, P, Paja, M, Villar-Taibo, R, Pena, A, Vicente, A, Guerrero-Pérez, F, Cordido, F, Aulinas, A, Mateu, M, Soto, A. Natural history and surgical outcomes of Rathke's cleft cysts: a Spanish multicenter study. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1413810. PMID:38952395. IF:4.600(Q1/3D).

12/06/2024 Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

Biagetti, B, Araujo-Castro, M, Torre, EM, Novoa-Testa, I, Cordido, F, Corrales, EP, Berrocal, VR, Guerrero-Perez, F, Vicente, A, Percovich, JC, Centeno, RG, Gonzalez, L, Garcia, MDO, Echarri, AI, Rodriguez, MDM, Novo-Rodriguez, C, Calatayud, M, Villar-Taibo, R, Bernabeu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jimenez, C, Galiana, PA, Moreno, EV, Molero, IG, Iglesias, P, Blanco, C, De Lara, FVO, de Miguel, P, Mezquita, EL, Hanzu, F, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Roca, QA, Gracia, P, Cordova, JMR, Aviles, M, Asensio-Wandosel, D, Sampedro, M, Camara, R, Paja, M, Ruz-Caracuel, I, Fajardo-Montanana, C, Asanza, EC, Martinez-Saez, E, Marazuela, M, Puig-Domingo, M. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2024; 190(6)DOI:10.1093/ejendo/lvae053. PMID:38771697. IF:5.200(Q1/2D).

01/06/2024 Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey

Cherenko, M, Appelman-Dijkstra, NM, Zurita, ALP, Biermasz, NR, Dekkers, OM, Klok, FA, Reisch, N, Aulinas, A, Biagetti, B, Cannavo, S, Canu, L, Detomas, M, Devuyst, F, Falhammar, H, Feelders, RA, Ferrau, F, Gatto, F, Grasselli, C, van Houten, P, Hoybye, C, Isidori, AM, Kyrilli, A, Loli, P, Maiter, D, Nowak, E, Pivonello, R, Ragnarsson, O, Steenaard, R, Unger, N, van de Ven, A, Webb, SM, Yeste, D, Ahmed, SF, Pereira, AM. Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey. Endocrine Connections. 2024; 13(6)DOI:10.1530/EC-24-0046. PMID:38614126. IF:2.800(Q3/6D).

13/03/2024 PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly (vol 40, pg 671, 2023)

O'Toole, D, Kunz, PL, Webb, SM, Goldstein, G, Khawaja, S, McDonnell, M, Boiziau, S, Gueguen, D, Houchard, A, Ribeiro-Oliveira, A Jr, Prebtani, A. PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly (vol 40, pg 671, 2023). ADVANCES IN THERAPY. 2024; 41(6)DOI:10.1007/s12325-024-02829-6. PMID:38480663. IF:4.000(Q1/3D).

11/03/2024 The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery

Bryk-Wiazania, AH, Minasyan, M, Swiatkowska-Stodulska, R, Undas, A, Hubalewska-Dydejczyk, A, Webb, SM, Valassi, E, Gilis-Januszewska, A. The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1350010. PMID:38529392. IF:4.600(Q1/3D).

04/03/2024 Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases

Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Corrales, EP, Berrocal, VR, Guerrero-Pérez, F, Vicente, A, Percovich, JC, Centeno, RG, González, L, García, MDO, Echarri, AI, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar, R, Bernabéu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jimenéz, C, Galiana, PA, Moreno, EV, Molero, IG, Iglesias, P, Blanco, C, De Lara, FVO, de Miguel, P, Mezquita, EL, Hanzu, F, Aldecoa, I, Lamas, C, Aznar, S, Aulinas, A, Calabrese, A, Gracia, P, Recio-Córdova, JM, Aviles, M, Asensio-Wandosel, D, Sampedro, M, Ruz-Caracuel, I, Camara, R, Paja, M, Fajardo-Montañana, C, Marazuela, M, Puig-Domingo, M. Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2024; 109(12)DOI:10.1210/clinem/dgae126. PMID:38436926. IF:5.100(Q1/2D).

01/01/2024 New molecular tools for precision medicine in pituitary neuroendocrine tumors

Marques-Pamies, M, Gil, J, Valassi, E, Pons, L, Carrato, C, Jordà, M, Puig-Domingo, M. New molecular tools for precision medicine in pituitary neuroendocrine tumors. Minerva Endocrinology. 2024; 49(3)DOI:10.23736/S2724-6507.23.04063-0. PMID:38261299. IF:1.900(Q3/8D).

01/12/2023 Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly

Marques-Pamies, M, Gil, J, Jordà, M, Puig-Domingo, M. Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly. ARCHIVES OF MEDICAL RESEARCH. 2023; 54(8)DOI:10.1016/j.arcmed.2023.102924. PMID:38042683. IF:4.700(Q1/3D).

31/10/2023 Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly

Marques-Pamies, M, Gil, J, Valassi, E, Hernández, M, Biagetti, B, Giménez-Palop, O, Martínez, S, Carrato, C, Pons, L, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Librizzi, S, Calatayud, M, de Miguel, P, Alvarez-Escola, C, Picó, A, Sampedro, M, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Puig-Domingo, M. Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1269787. PMID:38027102. IF:3.900(Q2/3D).

02/08/2023 Oxytocin response to food intake in avoidant/restrictive food intake disorder

Aulinas, A, Muhammed, M, Becker, KR, Asanza, E, Hauser, K, Stern, C, Gydus, J, Holmes, T, Murray, HB, Breithaupt, L, Micali, N, Misra, M, Eddy, KT, Thomas, JJ, Lawson, EA. Oxytocin response to food intake in avoidant/restrictive food intake disorder. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2023; 189(2)DOI:10.1093/ejendo/lvad087. PMID:37474111. IF:5.300(Q1/2D).

01/08/2023 Quality of life in pituitary diseases.

Webb SM, Valassi E. Quality of life in pituitary diseases.. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endien.2023.03.021. PMID:37516611. IF:(Q/D).

05/06/2023 Gut microbial dysbiosis in patients with Cushing's disease in long-term remission. Relationship with cardiometabolic risk

Valassi E., Manichanh C., Amodru V., Fernández P.G., Gaztambide S., Yanez, F, Martel-Duguech L., Puig-Domingo M., Webb S.M.. Gut microbial dysbiosis in patients with Cushing's disease in long-term remission. Relationship with cardiometabolic risk. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1074757. PMID:37342265. IF:3.900(Q2/3D).

05/04/2023 Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome

Amodru, V, Ferriere, A, Tabarin, A, Castinetti, F, Tsagarakis, S, Toth, M, Feelders, RA, Webb, SM, Reincke, M, Netea-Maier, R, Kastelan, D, Elenkova, A, Maiter, D, Ragnarsson, O, Santos, A, Valass, E, ERCUSYN Study Grp. Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2023; 188(4)DOI:10.1093/ejendo/lvad008. PMID:36749009. IF:5.300(Q1/2D).

14/03/2023 Mortality in Acromegaly Diagnosed in Older Individuals in Spain Is Higher in Women Compared to the General Spanish Population

Biagetti, B, Iglesias, P, Villar-Taibo, R, Moure, MD, Paja, M, Araujo-Castro, M, Ares, J, Alvarez-Escola, C, Vicente, A, Guivernau, EA, Novoa-Testa, I, Perez, FG, Camara, R, Lecumberri, B, Gomez, CG, Bernabeu, I, Manjon, L, Gaztambide, S, Cordido, F, Webb, SM, Menendez-Torre, EL, Diez, JJ, Simo, R, Puig-Domingo, M. Mortality in Acromegaly Diagnosed in Older Individuals in Spain Is Higher in Women Compared to the General Spanish Population. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2023; 108(9)DOI:10.1210/clinem/dgad141. PMID:36916151. IF:5.000(Q1/2D).

01/01/2023 PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly

O'Toole, D, Kunz, PL, Webb, SM, Goldstein, G, Khawaja, S, McDonnell, M, Boiziau, S, Gueguen, D, Houchard, A, Jr, ARO, Prebtani, A. PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly. ADVANCES IN THERAPY. 2023; 40(2)DOI:10.1007/s12325-022-02360-6. PMID:36502449. IF:3.400(Q2/3D).

01/01/2023 Quality of life in pituitary diseases

Webb S.M., Valassi E.. Quality of life in pituitary diseases. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endinu.2023.03.001. PMID:. IF:(Q/D).

01/12/2022 Patient journey experiences may contribute to improve healthcare for patients with rare endocrine diseases

Webb, SM, Kristensen, J, Nordenstrom, A, Vitali, D, Amodru, V, Wiehe, LK, Bolz-Johnson, M. Patient journey experiences may contribute to improve healthcare for patients with rare endocrine diseases. Endocrine Connections. 2022; 11(12)DOI:10.1530/EC-22-0385. PMID:36228311. IF:2.900(Q3/8D).

01/10/2022 Quality of life impairment after a diagnosis of Cushing's syndrome

Webb, SM, Valassi, E. Quality of life impairment after a diagnosis of Cushing's syndrome. Pituitary. 2022; 25(5)DOI:10.1007/s11102-022-01245-9. PMID:35767164. IF:3.800(Q2/5D).

16/09/2022 Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain

Biagetti, B, Iglesias, P, Villar-Taibo, R, Moure, MD, Paja, M, Araujo-Castro, M, Ares, J, Alvarez-Escola, C, Vicente, A, Guivernau, EA, Novoa-Testa, I, Perez, FG, Camara, R, Lecumberri, B, Gomez, CG, Bernabeu, I, Manjon, L, Gaztambide, S, Cordido, F, Webb, SM, Menendez-Torre, EL, Diez, JJ, Simo, R, Puig-Domingo, M. Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.984877. PMID:36187107. IF:5.200(Q1/3D).

18/08/2022 Consequences of Cushing's Syndrome: Health Versus Personal Costs

Webb, SM, Valassi, E. Consequences of Cushing's Syndrome: Health Versus Personal Costs. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022; 107(9)DOI:10.1210/clinem/dgac269. PMID:35511590. IF:5.800(Q1/3D).

08/08/2022 Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing's disease in remission

Pupier, E, Santos, A, Etchamendy, N, Lavielle, A, Ferriere, A, Marighetto, A, Resmini, E, Cota, D, Webb, SM, Tabarin, A. Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing's disease in remission. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.934347. PMID:36004342. IF:5.200(Q1/3D).

01/07/2022 Attachment-Based Compassion Therapy for Reducing Anxiety and Depression in Fibromyalgia

Santos, A, Crespo, I, Perez-Aranda, A, Beltran-Ruiz, M, Puebla-Guedea, M, Garcia-Campayo, J. Attachment-Based Compassion Therapy for Reducing Anxiety and Depression in Fibromyalgia. International Journal of Environmental Research and Public Health. 2022; 19(13)DOI:10.3390/ijerph19138152. PMID:35805810. IF:4.614(Q1/3D).

01/06/2022 Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience

Salvatori, R, Maffei, P, Webb, SM, Brue, T, Loftus, J, Valluri, SR, Gomez, R, Wajnrajch, MP, Fleseriu, M. Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience. Pituitary. 2022; 25(3)DOI:10.1007/s11102-022-01206-2. PMID:35022929. IF:3.800(Q2/5D).

28/05/2022 Data mining analyses for precision medicine in acromegaly: a proof of concept

Gil, J, Marques-Pamies, M, Sampedro, M, Webb, SM, Serra, G, Salinas, I, Blanco, A, Valassi, E, Carrato, C, Pico, A, Garcia-Martinez, A, Martel-Duguech, L, Sardon, T, Simo-Servat, A, Biagetti, B, Villabona, C, Camara, R, Fajardo-Montanana, C, Alvarez-Escola, C, Lamas, C, Alvarez, CV, Bernabeu, I, Marazuela, M, Jorda, M, Puig-Domingo, M. Data mining analyses for precision medicine in acromegaly: a proof of concept. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-12955-2. PMID:35643771. IF:4.600(Q2/4D).

01/02/2022 Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer

Pardo, JC, de Porras, VR, Gil, J, Font, A, Puig-Domingo, M, Jorda, M. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer. Nutrients. 2022; 14(4)DOI:10.3390/nu14040851. PMID:35215499. IF:5.900(Q1/2D).

01/01/2022 Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)

van Haalen F.M., Kaya M., Pelsma I.C.M., Cannegieter S.C., Huisman M.V., van Vlijmen B.J.M., Feelders R.A., Stochholm K., Fliers E., Castinetti F., Brue T., Bertherat J., Scaroni C., Colao A., Giordano R., Druce M.R., Beckers A., Spranger J., Driessens N., Maiter D., Feldt-Rasmussen U., Feelders R., Webb S.M., Dattani M., Husebye E., Zilaitiene B., Gaztambide S., Gatto F., Ferone D., Persani L., Chiodini I., Höybye C., Pereira A.M., Biermasz N.R., Klok F.A., Dekkers O.M., Meijer O.C., Reincke M., Vila G., Perry C., Heck A., Stancampiano M.R., van de Ven A., Johannsson G., Ragnarsson O., Tóth M., Volke V., Toumba M., Canu L., Vojtková J., Al-Mrayat M., Fassnacht M., Detomas M., Karavitaki N., van der Klauw M.M., Groselj U., Elenkova A., Unuane D.. Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02320-x. PMID:35505430. IF:3.700(Q2/4D).

01/12/2025 Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors

Araujo-Castro, M, Torre, EM, Lozano-Aida, C, Garcia-Centeno, R, Fernandez, LG, Idrobo, C, Achote-Rea, E, Echarri, AI, Rodriguez-Argullo, MDM, Paja, M, Guerrero-Perez, F, Castano, JP, Garcia, MDO, Novo-Rodriguez, C, Tenorio-Jimenez, C, Villar-Taibo, R, Bernabeu, I, Diaz-Lopez, E, Calatayud, M, Alvarez-Escola, C, Rojas-Marcos, PM, Recio-Cordova, JM, Aulinas, A, Roca, QA, Aviles, MD, Mezquita, EL, Fernandez-Argueeso, M, Molero, IG, Ruz-Caracuel, I, Aldecoa, I, Garcia, J, Martinez-Saez, E, Hanzu, F, Marazuela, M, Puig-Domingo, M, Biagetti, B. Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(12)DOI:10.1210/clinem/dgaf252. PMID:40277238. IF:5.100(Q1/2D).

01/12/2025 Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With Obesity

Aulinas, A, Galbiati, F, Wronski, ML, Carter, CS, Nazarloo, S, Holman, K, Golden, ER, Muhammed, M, Hadaway, N, Asanza, E, Smith, SE, Plessow, F, Lawson, EA. Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With Obesity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(12)DOI:10.1210/clinem/dgaf237. PMID:40314146. IF:5.100(Q1/2D).

01/12/2025 Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study

Biagetti, B, Cardona-Arias, A, Torre, EM, Aulinas, A, Ruz-Caracuel, I, Centeno, RG, Gonzalez, L, Echarri, AI, Rodriguez, MDM, Paja, M, Guerrero-Perez, F, Castano, JP, Garcia, MDO, Novo-Rodriguez, C, Tenorio-Jimenez, C, Villar-Taibo, R, Bernabeu, I, Diaz-Lopez, E, Calatayud, M, Alvarez-Escola, C, Rojas-Marcos, PM, Recio-Cordova, JM, Lozano-Aida, C, Roca, QA, Aviles, MD, Mezquita, EL, Argueso, MF, Molero, IG, Alberoa, I, Idrobo, C, Achote, E, Martinez-Saez, E, Marazuela, M, Puig-Domingo, M, Hanzu, F, Araujo-Castro, M. Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2025; 48(12)DOI:10.1007/s40618-025-02674-6. PMID:40779234. IF:3.500(Q2/4D).

01/11/2025 Oxytocin in hypopituitarism: What do we know?

Aulinas, A, Lawson, EA. Oxytocin in hypopituitarism: What do we know?. Endocrinologia Diabetes y Nutricion. 2025; 72(9)DOI:. PMID:41173566. IF:1.800(Q3/8D).